Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2008
10/28/2008US7442794 Stereoisomers ; reacting with Lewis acid; purification
10/28/2008US7442790 Caspase inhibitors and uses thereof
10/28/2008US7442713 2-thio-substituted imidazole derivatives and their use in pharmaceutics
10/28/2008US7442708 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
10/28/2008US7442704 Amide derivatives
10/28/2008US7442703 Piperidine derivatives useful as CCR5 antagonists
10/28/2008US7442701 Amino-heterocycles as VR-1 antagonists for treating pain
10/28/2008US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide
10/28/2008US7442697 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
10/28/2008US7442546 Method of modulating inflammatory response
10/28/2008US7442386 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
10/28/2008US7442368 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation
10/28/2008CA2472107C Dibenzodiazepine derivates, their preparation and use
10/28/2008CA2442227C Ccr5 antagonists useful for treating aids
10/28/2008CA2433765C Use of botulinum toxin for treatment of articular pathologies
10/28/2008CA2417652C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2403152C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2373868C Compositions comprising organosiloxane resins for delivering oral care substances
10/23/2008WO2008128045A1 Solid forms of (e) -1- (4- ( (1r, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl)ethanone oxime
10/23/2008WO2008126940A1 Novel t cell
10/23/2008WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
10/23/2008WO2008126752A1 Skin-lightening agent containing equol compound as active ingredient
10/23/2008WO2008126732A1 Fused bicyclic heteroaryl derivatives
10/23/2008WO2008125800A2 Mmp activated vascular disrupting agents
10/23/2008WO2008125724A1 Estimation and biological consequences of oxidative metabolism
10/23/2008WO2008125674A1 Use of dimiracetam in the treatment of chronic pain
10/23/2008WO2008125600A2 Pyrazole derivatives as p2x7 modulators
10/23/2008WO2008125570A1 New bradykinin b1 antagonists
10/23/2008WO2008125296A1 Vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/23/2008WO2008125215A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses
10/23/2008WO2008125210A1 Quinoline and naphthalene derivatives, processes for their preparation and their use in treatment of inflammatory diseases
10/23/2008WO2008125014A1 Urea compounds, preparation methods and pharmaceutical uses thereof
10/23/2008WO2008124857A2 Plant extract, and use thereof
10/23/2008WO2008100463B1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
10/23/2008WO2008064829A3 Novel aminothienopyridinone derivatives processes for preparing them and pharmaceutical compositions thereof
10/23/2008WO2008035315A9 Inhibitors of phosphodiesterase type-iv
10/23/2008WO2007046022A3 Inhibitors of phosphodiesterase type-iv
10/23/2008US20080262205 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
10/23/2008US20080262197 Methods and materials for treating inflammatory conditions
10/23/2008US20080262079 Cannabinoid Compositions and Methods of Use Thereof
10/23/2008US20080262071 Pindolol for the Treating Premenstrual Syndrome and Premenstrual Dysphoric Disorder
10/23/2008US20080262068 Method of Tonic Treatment With Oxyphenbutazone Derivatives
10/23/2008US20080262062 disease treatable with PARP modulators by identifying a level of PARP in a plurality of samples from a population, making a decision regarding identifying the disease treatable by the PARP modulators wherein the decision is made based on the level of PARP
10/23/2008US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
10/23/2008US20080262037 Piperidine Derivatives for the Treatment of Chemokine Mediated Disease
10/23/2008US20080262032 Isoxazoline Derivative and Novel Process for Its Preparation
10/23/2008US20080262018 Treating allergic and inflammatory conditions
10/23/2008US20080262016 Isoquinoline derivatives and methods of use thereof
10/23/2008US20080262013 Oxymorphone controlled release formulations
10/23/2008US20080261987 Substituted piperazines
10/23/2008US20080261984 Use of S,S-Reboxetine in the Treatment of Pain
10/23/2008US20080261977 Pyrimidine Derivatives as Cannabinoid Receptor Modulators
10/23/2008US20080261976 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
10/23/2008US20080261966 Bis-aryl sulfonamides
10/23/2008US20080261960 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261946 Pyrimidine Compounds for the Treatment of Inflammatory Disorders
10/23/2008US20080261943 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
10/23/2008US20080261930 Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
10/23/2008US20080261893 Contains neo-tryptophan; transdermal patches
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261867 Soluble inhibitors of vascular endothelial growth factor and use thereof
10/23/2008US20080261865 Oxidized Lipids and Uses Thereof in the Treatment of Inflammatory Diseases and Disorders
10/23/2008US20080261862 Integrin mediates proliferative signal provided by CD23 to pre-B cells; immobilized rodent cells; drug screening; anticancer agents; antiinflammatory agents
10/23/2008US20080260817 Such as celecoxib with 2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)benzoic acid; cyclooxygenase 2 (Cox 2), leukotriene B4 (Ltb4); arthritis
10/23/2008US20080260812 Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta)
10/23/2008US20080260791 Reducing pain; in situ administering dosage
10/23/2008US20080260757 Bispecific Fusion Antibodies With Enhanced Serum Half-Life
10/23/2008US20080260752 Prevention and reduction of blood loss
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260718 Phospholipase C Gamma Modulation and Uses Thereof for Management of Pain and Nociception
10/23/2008US20080260650 Administering diagnostic agent and immunology moderator; detecting inflammed tissue
10/23/2008DE102007018151A1 Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments
10/23/2008DE102007018150A1 Treating pain, using dual action compound or combination of compounds with affinity for both mu-opioid and vanilloid VR1-receptors, also effective e.g. against coughs or asthma
10/23/2008DE102007018149A1 Substituted compound for producing pharmaceuticals for treating or prophylaxis of pain, nerve injuries, respiratory disorder, has general formulae
10/23/2008CA2684363A1 Use of dimiracetam in the treatment of chronic pain
10/23/2008CA2683963A1 Solid forms of (e) -1- (4- ( (ir, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime
10/23/2008CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1982990A1 Cytokine receptor common gamma chain like
10/22/2008EP1982986A1 Pyrrolopyridazinone compound
10/22/2008EP1982984A2 Tricyclic thrombin receptor antagonists
10/22/2008EP1982713A2 Substituted benzoxazoles and analogues as estrogenic agents
10/22/2008EP1982701A2 Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
10/22/2008EP1982008A1 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration
10/22/2008EP1981913A2 Antibodies that bind par-2
10/22/2008EP1981862A2 Lanthionine-related compounds for the treatment of inflammatory diseases
10/22/2008EP1981852A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
10/22/2008EP1981851A1 Kinase inhibitors and methods of use thereof
10/22/2008EP1660461B1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases
10/22/2008EP1648879B1 Heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain
10/22/2008EP1549652B1 Fused azole-pyrimidine derivatives
10/22/2008EP1472257B1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
10/22/2008EP1375518B1 Anti-osteopontin antibody and use thereof
10/22/2008EP1318983B1 Substituted imidazoles as histamine h1 and h3 agonists or antagonists
10/22/2008EP0787011B1 microemulsion preconcentrate comprising a macrolide
10/22/2008CN101291947A Crystalline forms of macrolide compounds endowed with antiinflammatory activity
10/22/2008CN101291914A Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases
10/22/2008CN101291681A Cytokine modulators and related methods of use
10/22/2008CN101291671A Liquid preparation for external application containing indomethacin
1 ... 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 ... 1272